IL-13-associated epithelial remodeling correlates with clinical severity in nasal polyposis

Area of Science:

• Immunology
• Cell Biology
• Respiratory Medicine

Background:

• Epithelial remodeling is a hallmark of chronic inflammatory airway diseases like chronic rhinosinusitis (CRS).
• The specific cell-type shifts and their links to CRS endotypes and disease severity remain unclear.
• Understanding these cellular changes is crucial for targeted therapies.

Purpose of the Study:

• To investigate the relationship between epithelial cell remodeling, inflammatory endotypes, and clinical outcomes in CRS.
• To differentiate the cellular and molecular signatures of CRS with nasal polyps versus CRS without polyps.
• To correlate epithelial cell alterations with disease severity metrics.

Main Methods:

• Analysis of bulk RNA-sequencing data from sinus epithelial brushings.
• Utilized cell-type transcriptional signatures from single-cell sequencing of epithelial cells.
• Compared patients with CRS (with and without nasal polyps) to healthy controls.

Main Results:

• Nasal polyposis exhibited increased tuft cell and decreased ciliated cell transcripts, alongside an IL-13 activation signature.
• CRS without polyps demonstrated an IL-17 activation signature.
• IL-13 activation scores correlated with increased tuft, goblet, and mast cell scores, and decreased ciliated cell scores.
• IL-13 scores linked to activated tuft cells, prostaglandin E2, and higher Lund-Mackay scores (sinus opacification).

Conclusions:

• Cell-type alterations and prostaglandin E2 are key in IL-13-driven epithelial remodeling in nasal polyposis.
• IL-17 signaling is more prominent in CRS without polyps.
• Clinical severity of CRS correlates with the extent of IL-13-mediated epithelial remodeling.